Abstract
Tumor necrosis factor alpha (TNF-alpha) is a major inflammatory mediator that exhibits actions leading to tissue destruction and hampering recovery from damage. At present, two antibodies against human TNF-alpha (hTNF-alpha) are available, which are widely used for the clinic treatment of certain inflammatory diseases. This work was undertaken to identify a novel functional epitope of hTNF-alpha. We performed screening peptide library against anti-hTNF-alpha antibodies, ELISA and competitive ELISA to obtain the epitope of hTNF-alpha. The key residues of the epitope were identified by means of combinatorial alanine scanning and site-specific mutagenesis. The N terminus (80-91 aa) of hTNF-alpha proved to be a novel epitope (YG1). The two amino acids of YG1, proline and valine, were identified as the key residues, which were important for hTNF-alpha biological function. Furthermore, the function of the epitope was addressed on an animal model of collagen-induced arthritis (CIA). CIA could be suppressed in an animal model by prevaccination with the derivative peptides of YG1. The antibodies of YG1 could also inhibit the cytotoxicity of hTNF-alpha. These results demonstrate that YG1 is a novel epitope associated with the biological ...Continue Reading
References
Sep 1, 1991·Arthritis and Rheumatism·G S FiresteinB H Littman
Sep 1, 1989·Immunology Today·F R Balkwill, F Burke
Aug 1, 1988·Arthritis and Rheumatism·T SaxneF A Wollheim
Sep 1, 1988·Annals of the Rheumatic Diseases·F S Di GiovineG W Duff
Oct 22, 1994·Lancet·M J ElliottH Bijl
Dec 1, 1993·Arthritis and Rheumatism·M J ElliottJ Ghrayeb
Jul 1, 1995·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·N L Ascher
Mar 6, 1998·Protein Engineering·C ReedI T Weber
Jan 6, 2000·Lancet·R MainiP Lipsky
Sep 18, 2003·Arthritis and Rheumatism·Masataka NishikawaHideki Yoshikawa
Jul 23, 2005·Circulation Research·Zamaneh KassiriRama Khokha
Jan 28, 2006·Annals of the Rheumatic Diseases·M H SchiffC Donovan
Sep 2, 2006·Arthritis and Rheumatism·Soko SetoguchiSebastian Schneeweiss
May 17, 2007·Rheumatology·S BombardieriUNKNOWN Research in Active Rheumatoid Arthritis (ReAct) Study Group
Oct 6, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Maida WongRam Raj Singh
Oct 6, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jan LinRam Raj Singh
Nov 16, 2007·The Journal of Biological Chemistry·Hiroko ShibataYasuo Tsutsumi
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Nov 20, 2008·Autoimmunity Reviews·Roberto CaporaliCarlomaurizio Montecucco
Nov 26, 2008·Autoimmunity Reviews·Chiara BazzaniRoberto Gorla
Jan 23, 2009·Lancet·Lars KlareskogStephen Paget
May 5, 2009·Nature Reviews. Rheumatology·Mark C Fisher, Jeffrey D Greenberg
Jun 6, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Laura J Gibbons, Kimme L Hyrich
Citations
Nov 20, 2013·Arthritis Research & Therapy·Daniela ImpellizzeriSalvatore Cuzzocrea
Oct 6, 2012·Biological & Pharmaceutical Bulletin·Renata GrespanRoberto Kenji Nakamura Cuman
Feb 20, 2013·Cell Biochemistry and Biophysics·Ya-ping GaoGuang Yang
Apr 3, 2012·International Immunopharmacology·Mansheng LuoJimin Gao
Apr 21, 2016·European Journal of Pharmacology·E EspositoS Cuzzocrea
Jul 19, 2011·The Journal of Rheumatology·Emanuela MazzonSalvatore Cuzzocrea
Sep 2, 2011·The Journal of Pharmacology and Experimental Therapeutics·Daniela ImpellizzeriSalvatore Cuzzocrea
Sep 25, 2015·PloS One·Yinglan ZhaoSongqing Liu